Edition:
United States

Acrux Ltd (ACR.AX)

ACR.AX on Australia Stock Exchange

0.31AUD
6:36pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.31
Open
$0.32
Day's High
$0.32
Day's Low
$0.31
Volume
178,271
Avg. Vol
451,431
52-wk High
$0.83
52-wk Low
$0.31

ACR.AX

Chart for ACR.AX

About

Acrux Limited is a drug development company. The Company is engaged in developing and commercializing branded and generic transdermal and topical pharmaceuticals for global markets. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutic... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $54.12
Shares Outstanding(Mil.): 166.52
Dividend: 0.06
Yield (%): 18.46

Financials

  ACR.AX Industry Sector
P/E (TTM): 4.12 29.13 29.87
EPS (TTM): 0.08 -- --
ROI: 27.94 15.56 14.95
ROE: 30.72 16.69 16.29

BRIEF-Acrux Ltd files inter partes review petition against Key Jublia Patent

* Acrux files inter partes review petition against Key Jublia Patent Source text for Eikon: Further company coverage:

Nov 02 2016

BRIEF-Acrux filed new provisional patent application covering its pipeline product acr-065

* Filed a new provisional patent application covering its pipeline product acr-065 which is targeting fungal infection of nail bed in toes and fingers

Nov 01 2016

BRIEF-Acrux Ltd appoints Tim Bateman as Chief Financial Officer

* Tim bateman has been appointed to role of Chief Financial Officer and Company Secretary

Oct 09 2016

Earnings vs. Estimates